Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ghana | 13 | 2021 | 315 | 0.940 |
Why?
|
Panax | 3 | 2001 | 28 | 0.500 |
Why?
|
Women's Health | 4 | 2011 | 2070 | 0.400 |
Why?
|
Breast Self-Examination | 1 | 2011 | 33 | 0.390 |
Why?
|
Faculty, Medical | 3 | 2004 | 1205 | 0.370 |
Why?
|
Breast Neoplasms | 21 | 2021 | 20982 | 0.370 |
Why?
|
Self Concept | 2 | 2007 | 1046 | 0.360 |
Why?
|
Attitude to Health | 3 | 2011 | 2026 | 0.350 |
Why?
|
Health Status | 4 | 2012 | 4077 | 0.330 |
Why?
|
Overweight | 2 | 2018 | 2418 | 0.310 |
Why?
|
Urban Population | 2 | 2007 | 2036 | 0.310 |
Why?
|
Plants, Medicinal | 2 | 1999 | 165 | 0.290 |
Why?
|
Hypertension | 5 | 2019 | 8536 | 0.280 |
Why?
|
Carcinoembryonic Antigen | 6 | 1990 | 335 | 0.270 |
Why?
|
Obesity | 7 | 2018 | 12940 | 0.260 |
Why?
|
Cultural Characteristics | 1 | 2007 | 250 | 0.260 |
Why?
|
Health Status Indicators | 1 | 2011 | 970 | 0.260 |
Why?
|
Body Image | 2 | 2007 | 639 | 0.250 |
Why?
|
Career Mobility | 2 | 2004 | 259 | 0.240 |
Why?
|
Teaching | 1 | 2011 | 1171 | 0.220 |
Why?
|
Menarche | 1 | 2006 | 532 | 0.220 |
Why?
|
BCG Vaccine | 2 | 1996 | 369 | 0.210 |
Why?
|
Physician Executives | 1 | 2004 | 134 | 0.210 |
Why?
|
Sexually Transmitted Diseases | 1 | 2008 | 662 | 0.210 |
Why?
|
Melanoma, Experimental | 2 | 1996 | 561 | 0.200 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2003 | 890 | 0.200 |
Why?
|
Small-Area Analysis | 1 | 2021 | 52 | 0.200 |
Why?
|
Hospitals, Teaching | 3 | 2021 | 1155 | 0.200 |
Why?
|
Chronic Disease | 2 | 2019 | 9319 | 0.190 |
Why?
|
Health Surveys | 5 | 2021 | 4037 | 0.190 |
Why?
|
Censuses | 1 | 2021 | 198 | 0.180 |
Why?
|
Cyclins | 1 | 2001 | 594 | 0.160 |
Why?
|
Health Promotion | 1 | 2011 | 2205 | 0.160 |
Why?
|
Mentors | 1 | 2004 | 663 | 0.160 |
Why?
|
Clothing | 1 | 2019 | 96 | 0.150 |
Why?
|
Drugs, Chinese Herbal | 1 | 1999 | 143 | 0.150 |
Why?
|
Age Distribution | 2 | 2018 | 2871 | 0.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2011 | 4014 | 0.140 |
Why?
|
Sampling Studies | 1 | 2018 | 615 | 0.140 |
Why?
|
Early Detection of Cancer | 1 | 2011 | 3198 | 0.140 |
Why?
|
Cost of Illness | 1 | 2006 | 1936 | 0.130 |
Why?
|
Mastectomy | 2 | 2021 | 1818 | 0.130 |
Why?
|
Indium Radioisotopes | 3 | 1990 | 113 | 0.130 |
Why?
|
Transcriptional Activation | 1 | 2001 | 1749 | 0.130 |
Why?
|
Health Behavior | 1 | 2006 | 2641 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3200 | 0.120 |
Why?
|
Tumor Cells, Cultured | 7 | 2001 | 6125 | 0.120 |
Why?
|
Leadership | 1 | 2004 | 1385 | 0.120 |
Why?
|
Antibodies, Monoclonal | 10 | 1997 | 9187 | 0.110 |
Why?
|
Tamoxifen | 4 | 2007 | 965 | 0.110 |
Why?
|
Sex Distribution | 1 | 2018 | 2277 | 0.110 |
Why?
|
Indium | 3 | 1986 | 47 | 0.110 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7804 | 0.110 |
Why?
|
Body Mass Index | 4 | 2021 | 12952 | 0.100 |
Why?
|
Radioimmunodetection | 1 | 1992 | 45 | 0.100 |
Why?
|
Female | 37 | 2021 | 392552 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 1993 | 321 | 0.100 |
Why?
|
Interleukin-2 | 2 | 1996 | 1891 | 0.100 |
Why?
|
Radioimmunotherapy | 1 | 1992 | 90 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 2 | 1993 | 1158 | 0.100 |
Why?
|
Nicaragua | 1 | 2011 | 29 | 0.100 |
Why?
|
Cystadenocarcinoma | 1 | 1991 | 54 | 0.100 |
Why?
|
Interferon-gamma | 3 | 1997 | 3155 | 0.090 |
Why?
|
Radioisotopes | 3 | 1986 | 502 | 0.090 |
Why?
|
Colonic Neoplasms | 6 | 1990 | 2527 | 0.090 |
Why?
|
Cell Division | 6 | 2003 | 4451 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 1993 | 4513 | 0.090 |
Why?
|
Occupational Diseases | 1 | 2019 | 1490 | 0.090 |
Why?
|
Adult | 23 | 2021 | 221120 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2007 | 1520 | 0.090 |
Why?
|
Middle Aged | 21 | 2018 | 220858 | 0.080 |
Why?
|
Estrogens | 1 | 1996 | 1522 | 0.080 |
Why?
|
Sarcoma | 2 | 1993 | 1800 | 0.080 |
Why?
|
Breast Diseases | 1 | 1993 | 443 | 0.080 |
Why?
|
Receptors, Progesterone | 1 | 1994 | 1129 | 0.080 |
Why?
|
Humans | 52 | 2021 | 761222 | 0.080 |
Why?
|
Body Size | 1 | 2012 | 463 | 0.080 |
Why?
|
Neoplasms, Unknown Primary | 1 | 1990 | 101 | 0.080 |
Why?
|
DNA, Neoplasm | 5 | 1993 | 1743 | 0.080 |
Why?
|
Gene Amplification | 1 | 1993 | 1084 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 26072 | 0.080 |
Why?
|
Blood Pressure | 3 | 2021 | 8479 | 0.070 |
Why?
|
Prevalence | 4 | 2011 | 15721 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4618 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 1996 | 3594 | 0.070 |
Why?
|
Demography | 2 | 2008 | 1641 | 0.070 |
Why?
|
Contraception Behavior | 1 | 2009 | 180 | 0.070 |
Why?
|
Receptors, Estrogen | 2 | 1994 | 2208 | 0.070 |
Why?
|
Social Conformity | 1 | 2006 | 39 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2001 | 12747 | 0.070 |
Why?
|
Antigens, Surface | 1 | 1991 | 1607 | 0.070 |
Why?
|
Risk Factors | 8 | 2018 | 74241 | 0.070 |
Why?
|
Family Planning Services | 1 | 2009 | 267 | 0.060 |
Why?
|
Reproductive Medicine | 1 | 2007 | 99 | 0.060 |
Why?
|
Adolescent | 8 | 2011 | 88300 | 0.060 |
Why?
|
Contraception | 1 | 2009 | 347 | 0.060 |
Why?
|
Mammography | 3 | 2011 | 2430 | 0.060 |
Why?
|
HIV Seroprevalence | 1 | 2005 | 89 | 0.060 |
Why?
|
Flow Cytometry | 5 | 1999 | 5871 | 0.060 |
Why?
|
Life Expectancy | 1 | 2011 | 1242 | 0.060 |
Why?
|
Radionuclide Imaging | 7 | 1990 | 1989 | 0.060 |
Why?
|
Rectal Neoplasms | 4 | 1986 | 1156 | 0.060 |
Why?
|
Planning Techniques | 1 | 2004 | 82 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13249 | 0.060 |
Why?
|
Cancer Vaccines | 2 | 2003 | 1038 | 0.050 |
Why?
|
Genetic Counseling | 1 | 2007 | 628 | 0.050 |
Why?
|
Educational Status | 2 | 2009 | 2510 | 0.050 |
Why?
|
Mass Screening | 2 | 2019 | 5426 | 0.050 |
Why?
|
Parity | 1 | 2006 | 929 | 0.050 |
Why?
|
Aged | 12 | 2012 | 169292 | 0.050 |
Why?
|
Young Adult | 5 | 2019 | 59222 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 1991 | 1985 | 0.050 |
Why?
|
Social Class | 2 | 2012 | 1993 | 0.050 |
Why?
|
Ovarian Neoplasms | 2 | 2007 | 4872 | 0.050 |
Why?
|
Blotting, Southern | 2 | 1993 | 775 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3418 | 0.050 |
Why?
|
Staff Development | 1 | 2004 | 227 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2003 | 2915 | 0.050 |
Why?
|
Organizational Objectives | 1 | 2004 | 426 | 0.050 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2001 | 221 | 0.050 |
Why?
|
Malaria | 1 | 2011 | 1225 | 0.050 |
Why?
|
Proteins | 1 | 1996 | 5993 | 0.050 |
Why?
|
Physician's Role | 2 | 2004 | 920 | 0.050 |
Why?
|
Decision Making | 2 | 2006 | 3931 | 0.050 |
Why?
|
Anthropometry | 1 | 2006 | 1338 | 0.050 |
Why?
|
HT29 Cells | 1 | 2001 | 192 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 1996 | 6504 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1993 | 1545 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2021 | 80675 | 0.050 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 1995 | 926 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 361 | 0.040 |
Why?
|
Professional Competence | 1 | 2004 | 430 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2004 | 538 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 1993 | 748 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2004 | 545 | 0.040 |
Why?
|
Primary Prevention | 1 | 2007 | 1185 | 0.040 |
Why?
|
Geography | 1 | 2021 | 652 | 0.040 |
Why?
|
Counseling | 2 | 2004 | 1536 | 0.040 |
Why?
|
Systole | 1 | 2021 | 936 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 1992 | 6341 | 0.040 |
Why?
|
Diastole | 1 | 2021 | 782 | 0.040 |
Why?
|
Occupational Health Services | 2 | 2019 | 150 | 0.040 |
Why?
|
Developing Countries | 1 | 2011 | 2863 | 0.040 |
Why?
|
HIV Infections | 1 | 2005 | 17348 | 0.040 |
Why?
|
Behavior | 1 | 2021 | 540 | 0.040 |
Why?
|
Education, Medical, Continuing | 1 | 2004 | 825 | 0.040 |
Why?
|
BRCA1 Protein | 2 | 2003 | 1149 | 0.040 |
Why?
|
Regression Analysis | 3 | 2006 | 6345 | 0.040 |
Why?
|
Triglycerides | 1 | 2006 | 2457 | 0.040 |
Why?
|
Blood Glucose | 2 | 2019 | 6392 | 0.040 |
Why?
|
Menopause | 1 | 2006 | 1646 | 0.040 |
Why?
|
Plant Extracts | 1 | 2001 | 496 | 0.040 |
Why?
|
Injections, Intravenous | 2 | 1990 | 1376 | 0.040 |
Why?
|
Picibanil | 1 | 1997 | 10 | 0.040 |
Why?
|
Mobile Health Units | 1 | 2019 | 92 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2001 | 1518 | 0.040 |
Why?
|
Memory | 1 | 2007 | 2190 | 0.040 |
Why?
|
Mycobacterium bovis | 2 | 1997 | 146 | 0.040 |
Why?
|
Cholesterol | 1 | 2006 | 2902 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 6 | 1998 | 9278 | 0.040 |
Why?
|
Schools, Medical | 1 | 2004 | 878 | 0.040 |
Why?
|
Melanoma | 3 | 2003 | 5694 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2019 | 0.030 |
Why?
|
Bangladesh | 1 | 2019 | 732 | 0.030 |
Why?
|
Esthetics | 1 | 1998 | 327 | 0.030 |
Why?
|
Age Factors | 3 | 2009 | 18384 | 0.030 |
Why?
|
Pain | 1 | 2011 | 5072 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5869 | 0.030 |
Why?
|
Breast | 2 | 1996 | 1964 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2004 | 1401 | 0.030 |
Why?
|
Liver Neoplasms | 3 | 1990 | 4310 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 620 | 0.030 |
Why?
|
Drug Synergism | 1 | 1999 | 1756 | 0.030 |
Why?
|
RNA Helicases | 1 | 1996 | 142 | 0.030 |
Why?
|
RNA | 2 | 1996 | 2709 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3453 | 0.030 |
Why?
|
Interleukin-12 | 1 | 1997 | 578 | 0.030 |
Why?
|
Jews | 1 | 1996 | 356 | 0.030 |
Why?
|
Odds Ratio | 1 | 2006 | 9652 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2009 | 58952 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2756 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2329 | 0.030 |
Why?
|
Cadherins | 1 | 1998 | 902 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1409 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2004 | 2632 | 0.030 |
Why?
|
Mice | 8 | 2003 | 81330 | 0.030 |
Why?
|
Binding Sites | 1 | 2001 | 5988 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2006 | 12052 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 1993 | 2553 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1603 | 0.030 |
Why?
|
Education, Medical | 1 | 2004 | 1725 | 0.030 |
Why?
|
Neoplasm Metastasis | 3 | 2003 | 4909 | 0.020 |
Why?
|
Paclitaxel | 1 | 1999 | 1730 | 0.020 |
Why?
|
Th1 Cells | 1 | 1997 | 1042 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 1997 | 988 | 0.020 |
Why?
|
Immunotoxins | 1 | 1992 | 175 | 0.020 |
Why?
|
Comorbidity | 1 | 2006 | 10516 | 0.020 |
Why?
|
Mental Disorders | 1 | 2011 | 6823 | 0.020 |
Why?
|
Keratins | 1 | 1993 | 498 | 0.020 |
Why?
|
Cell Cycle | 1 | 1999 | 2926 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 1996 | 1057 | 0.020 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1993 | 249 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 1998 | 1084 | 0.020 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 1991 | 138 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 518 | 0.020 |
Why?
|
Massachusetts | 1 | 2004 | 8837 | 0.020 |
Why?
|
Lymphocytes | 1 | 1998 | 2603 | 0.020 |
Why?
|
Mice, Inbred C57BL | 4 | 1997 | 22128 | 0.020 |
Why?
|
Fibrocystic Breast Disease | 1 | 1991 | 103 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 1990 | 6919 | 0.020 |
Why?
|
Mastectomy, Radical | 1 | 1990 | 19 | 0.020 |
Why?
|
Citrates | 1 | 1990 | 133 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 2 | 2003 | 490 | 0.020 |
Why?
|
Citric Acid | 1 | 1990 | 123 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2019 | 1375 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 1998 | 3590 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2004 | 3885 | 0.020 |
Why?
|
Genetic Engineering | 3 | 2003 | 930 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1990 | 413 | 0.020 |
Why?
|
Quality of Life | 1 | 2011 | 13367 | 0.020 |
Why?
|
Estradiol | 1 | 1996 | 1937 | 0.020 |
Why?
|
Anemia | 1 | 2019 | 1504 | 0.020 |
Why?
|
Axilla | 1 | 1991 | 624 | 0.020 |
Why?
|
Protein Kinases | 1 | 1996 | 1607 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1993 | 2468 | 0.020 |
Why?
|
Animals | 9 | 2003 | 168089 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1998 | 2820 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 1998 | 2913 | 0.020 |
Why?
|
Mammaplasty | 1 | 1998 | 1232 | 0.020 |
Why?
|
Thyroid Neoplasms | 2 | 1992 | 2330 | 0.020 |
Why?
|
DNA | 2 | 1993 | 7189 | 0.020 |
Why?
|
Transfection | 1 | 1995 | 5748 | 0.020 |
Why?
|
Contraceptive Agents | 1 | 2009 | 144 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10756 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 1996 | 1852 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 7400 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 12159 | 0.020 |
Why?
|
Male | 7 | 2019 | 360703 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1994 | 1052 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 1996 | 2803 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 1990 | 2010 | 0.020 |
Why?
|
Transplantation, Autologous | 2 | 2003 | 2112 | 0.020 |
Why?
|
Risk Assessment | 1 | 2007 | 24022 | 0.020 |
Why?
|
Religion | 1 | 2009 | 376 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1992 | 1169 | 0.020 |
Why?
|
Ploidies | 3 | 1992 | 285 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 1990 | 785 | 0.020 |
Why?
|
Cytokines | 2 | 1998 | 7386 | 0.010 |
Why?
|
Prognosis | 6 | 1995 | 29688 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1990 | 1624 | 0.010 |
Why?
|
Time Factors | 1 | 2006 | 39957 | 0.010 |
Why?
|
Vaccination | 1 | 1997 | 3369 | 0.010 |
Why?
|
Pregnancy | 1 | 2006 | 29893 | 0.010 |
Why?
|
Neoplasm Staging | 3 | 1998 | 11119 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 1994 | 6819 | 0.010 |
Why?
|
Gene Expression | 2 | 1996 | 7571 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1988 | 13386 | 0.010 |
Why?
|
Peritoneal Neoplasms | 1 | 1990 | 710 | 0.010 |
Why?
|
Cohort Studies | 1 | 2006 | 41496 | 0.010 |
Why?
|
Testis | 1 | 1986 | 781 | 0.010 |
Why?
|
Neoplasms | 1 | 1992 | 22142 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 54437 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1988 | 1225 | 0.010 |
Why?
|
Spermatozoa | 1 | 1986 | 630 | 0.010 |
Why?
|
Chemoprevention | 1 | 2004 | 325 | 0.010 |
Why?
|
Recurrence | 1 | 1994 | 8457 | 0.010 |
Why?
|
Dietary Fats | 1 | 1990 | 1994 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1990 | 2381 | 0.010 |
Why?
|
Adenoma | 1 | 1992 | 2159 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1996 | 5783 | 0.010 |
Why?
|
Medical History Taking | 1 | 2004 | 773 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3727 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1996 | 8531 | 0.010 |
Why?
|
Reoperation | 1 | 1990 | 4303 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1990 | 6304 | 0.010 |
Why?
|
Spleen | 2 | 1997 | 2290 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1084 | 0.010 |
Why?
|
Radiography | 1 | 1990 | 6974 | 0.010 |
Why?
|
Lymph Nodes | 2 | 1986 | 3461 | 0.010 |
Why?
|
Learning | 1 | 2007 | 1737 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 1998 | 39127 | 0.010 |
Why?
|
Nipples | 1 | 1998 | 229 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3803 | 0.010 |
Why?
|
Transcription Factors | 1 | 1996 | 12101 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1998 | 584 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9616 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3777 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2317 | 0.010 |
Why?
|
Breast Implants | 1 | 1998 | 407 | 0.010 |
Why?
|
Boston | 1 | 2007 | 9327 | 0.010 |
Why?
|
RNA, Double-Stranded | 1 | 1996 | 290 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 1997 | 13632 | 0.010 |
Why?
|
Base Sequence | 2 | 1996 | 12404 | 0.010 |
Why?
|
Eosinophils | 1 | 1998 | 951 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1988 | 2263 | 0.010 |
Why?
|
Safety | 1 | 1998 | 1151 | 0.010 |
Why?
|
DNA Damage | 1 | 2003 | 2443 | 0.010 |
Why?
|
Population Surveillance | 1 | 1984 | 2598 | 0.010 |
Why?
|
Cell Survival | 1 | 2003 | 5778 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1994 | 914 | 0.010 |
Why?
|
Macrophages | 2 | 1998 | 5755 | 0.010 |
Why?
|
DEAD-box RNA Helicases | 1 | 1996 | 380 | 0.010 |
Why?
|
Skin Transplantation | 1 | 1998 | 1091 | 0.010 |
Why?
|
Disease Progression | 2 | 2003 | 13511 | 0.010 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 1998 | 1089 | 0.010 |
Why?
|
Carcinoma in Situ | 1 | 1998 | 791 | 0.010 |
Why?
|
Hyperplasia | 1 | 1996 | 1150 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 17598 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1998 | 703 | 0.010 |
Why?
|
Mice, Nude | 1 | 1998 | 3606 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2003 | 8519 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3253 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1990 | 18222 | 0.010 |
Why?
|
Public Health | 1 | 1984 | 2672 | 0.010 |
Why?
|
Discriminant Analysis | 1 | 1990 | 224 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1997 | 2359 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1997 | 1838 | 0.010 |
Why?
|
Family Health | 1 | 1995 | 1254 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 1995 | 955 | 0.010 |
Why?
|
Anxiety | 1 | 2004 | 4569 | 0.010 |
Why?
|
Genetic Markers | 1 | 1996 | 2599 | 0.010 |
Why?
|
Surgical Flaps | 1 | 1998 | 1670 | 0.010 |
Why?
|
Cell Line | 1 | 2003 | 15545 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 1996 | 982 | 0.000 |
Why?
|
Age of Onset | 1 | 1996 | 3307 | 0.000 |
Why?
|
Preoperative Care | 2 | 1987 | 2241 | 0.000 |
Why?
|
Dendritic Cells | 1 | 1998 | 2726 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1996 | 4107 | 0.000 |
Why?
|
Apoptosis | 1 | 2003 | 9478 | 0.000 |
Why?
|
Carcinoma | 1 | 1998 | 2330 | 0.000 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1990 | 549 | 0.000 |
Why?
|
Biopsy | 1 | 1998 | 6781 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16575 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1994 | 6200 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1988 | 20588 | 0.000 |
Why?
|
Patient Selection | 1 | 1997 | 4246 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 1728 | 0.000 |
Why?
|
Phospholipids | 1 | 1988 | 784 | 0.000 |
Why?
|
Romania | 1 | 1984 | 92 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 4947 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 17897 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2003 | 64681 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1996 | 11067 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1997 | 18927 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1998 | 10203 | 0.000 |
Why?
|
Immunotherapy | 1 | 1997 | 4642 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 1998 | 5809 | 0.000 |
Why?
|
Survival Analysis | 1 | 1990 | 10088 | 0.000 |
Why?
|
Survival Rate | 1 | 1990 | 12728 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 1990 | 12474 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1988 | 3571 | 0.000 |
Why?
|
Feeding Behavior | 1 | 1984 | 3183 | 0.000 |
Why?
|
Liver | 1 | 1986 | 7512 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1984 | 4487 | 0.000 |
Why?
|
Child | 1 | 1990 | 80154 | 0.000 |
Why?
|